ALFA Finder| Value | ₹0.11 Cr |
|---|
BSE filing, NSE: SMSPHARMA. Summary written from the filing by ALFA Finder's alert engine.
SMS Pharmaceuticals Ltd: key numbers
- Share price
- ₹498.55
- Market cap
- ₹4,420 Cr
- Revenue (annual)
- ₹886.9 Cr
- Net profit (annual)
- ₹102.0 Cr
- P/E (TTM)
- 37.8×Sector 43.0×
- Promoter holding
- 68.07%+0.00% QoQ
- FII holding
- 1.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SMS Pharmaceuticals Ltd
All →SMS Pharmaceuticals Results Update
SMS Pharmaceuticals released a press release on its Q2 and H1 FY27 results, showing strong growth. Management now expects FY27 revenue growth and EBITDA margins above earlier guidance.
SMS Pharmaceuticals Investor Presentation: Key Takeaways
Q2FY27 revenue ₹316 Cr (+30% YoY), EBITDA ₹68 Cr at 21% margin, PAT ₹40 Cr (+57%). Strategy: backward integration, high-value APIs, DMF/CEP filings, ₹280 Cr capex.
SMS Pharmaceuticals Management Change
SMS Pharmaceuticals' Company Secretary Thirumalesh Tumma resigned effective November 4, 2026. Manohar Mollama has been appointed as the new Company Secretary effective November 5, 2026.
SMS Pharmaceuticals Q2 FY27 Results: Net Profit ₹39.9 Cr, Up 57.7% YoY
SMS Pharmaceuticals Ltd reported revenue from operations of ₹316.1 Cr (+30.4% YoY) and net profit of ₹39.9 Cr (+57.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹39.9 Cr · +57.7% YoY
SMS Pharmaceuticals Legal & Regulatory
SMS Pharmaceuticals received an Income Tax appellate order under Section 250 dismissing its appeal for AY 2018-19. The company says there is no material impact and is reviewing next steps.
- Value
- ₹0.40 Cr
SMS Pharmaceuticals Legal & Regulatory
SMS Pharmaceuticals disclosed that the CIT(Appeals) dismissed its appeal against a ₹7.19 Crore income tax assessment for AY 2018-19. The company is reviewing the order and expects no material impact.
- Value
- ₹7.19 Cr
Other capital structure change announcements
All →Tata Steel Capital Structure Change
Tata Steel's stake in subsidiary CPDPL rose from 51% to 57.5% via conversion of preference shares. CPDPL remains a subsidiary; no fresh capital was subscribed.
Filatex India Capital Structure Change
Filatex India invested Rs.13.00 Crore by subscribing 1.30 crore rights shares of wholly owned subsidiary Ecosis at Rs.10. Funds support the polyester recycling project, loan repayment and working capital.
- Value
- ₹13.00 Cr
Zydus Lifesciences Capital Structure Change
LIC sold 20,242,068 Zydus Lifesciences shares via market sale, cutting its stake from 5.21 percent to 3.18 percent. Non-promoter SAST disclosure covering 28.08.2025 to 05.11.2026.
Indian Oil Corporation Capital Structure Change
LIC, a non-promoter shareholder, reported a market sale of 28,34,86,368 shares in Indian Oil, cutting its holding from 7.887% to 5.879%. No monetary value is stated.
- Promoter stake change
- -2.01%
Kirloskar Oil Engines Capital Structure Change
Kirloskar Oil Engines signed a shareholders' agreement with TPG for its subsidiary Arka Fincap. TPG's investment totals ₹800 Crore across two tranches, the second conditional.
- Value
- ₹800.0 Cr
Ace Software Exports Ltd Partly Paidup Capital Structure Change
Ace Software Exports approved a ₹30.25 second and final call on 54,71,101 partly paid shares. The record date is 20 November 2026.
- Value
- ₹16.55 Cr